Standout Papers
Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
2009
Vertebral Fracture Assessment (VFA) With a Densitometer Predicts Future Fractures in Elderly Women Unselected for Osteoporosis
2008
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
2010 Standout
Cost-Effectiveness of Vertebral Fracture Assessment to Detect Prevalent Vertebral Deformity and Select Postmenopausal Women With a Femoral Neck T-Score > −2.5 for Alendronate Therapy: A Modeling Study
2006
Origins and evolution of the Western diet: health implications for the 21st century1,2
2005 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
Risk assessment tools to identify women with increased risk of osteoporotic fracture: Complexity or simplicity? A systematic review
2013
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
2004
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Functional Disability and Health Care Expenditures for Older Persons
2001
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2008
The Health and Productivity Cost Burden of the “Top 10” Physical and Mental Health Conditions Affecting Six Large U.S. Employers in 1999
2003
UK clinical guideline for the prevention and treatment of osteoporosis
2017
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
Clodronate Reduces Vertebral Fracture Risk in Women With Postmenopausal or Secondary Osteoporosis: Results of a Double-Blind, Placebo-Controlled 3-Year Study
2004
A reappraisal of generic bisphosphonates in osteoporosis
2011
Is Radiographic Vertebral Fracture a Risk Factor for Mortality?
2007
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
2009
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis
2011
Vertebral Fractures
2011
The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture
2003
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
An Osteoporosis Clinical Pathway for the Medical Management of Patients with Low-Trauma Fracture
2002
Osteoporosis
2019 Standout
A comparison of case-finding strategies in the UK for the management of hip fractures
2012
A meta-analysis of previous fracture and subsequent fracture risk
2004
Fractures Between the Ages of 20 and 50 Years Increase Women's Risk of Subsequent Fractures
2002
Osteoporosis
2006
A reference standard for the description of osteoporosis
2007
Breast cancer
2016 Standout
Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
2011
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Minerals and vitamins in bone health: the potential value of dietary enhancement
2009
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial
2003
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007
Effect of impact exercise on bone mineral density in elderly women with low BMD: a population-based randomized controlled 30-month intervention
2005
Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis
2011
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Vertebral Fracture Assessment: The 2005 ISCD Official Positions
2006
An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women
2001
Health and Productivity: A Role for Occupational Health Professionals
2001
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
2007
Risk of Subsequent Fracture After Low-Trauma Fracture in Men and Women
2007
Guidance for the adjustment of FRAX according to the dose of glucocorticoids
2011
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
2004 Standout
Non-specific low back pain
2016 Standout
Intervention thresholds for osteoporosis in the UK
2004
Incident vertebral fractures and mortality in older women: a prospective study
2003
Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday
2008
Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
2004
Reduced Relative Risk of Fractures Among Users of Lithium
2005
Fracture liaison services: improving outcomes for patients with osteoporosis
2017
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
2008
Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice
2009
Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy
2005
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Use of a Decision Aid to Improve Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial
2011
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Intervention thresholds for osteoporosis
2002
The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder
2007 Standout
Low Frequency of Treatment of Osteoporosis Among Postmenopausal Women Following a Fracture
2003
Osteoporosis: now and the future
2011 Standout
Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study
2010
What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?
2010
A family history of fracture and fracture risk: a meta-analysis
2004
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden
2007
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study
2004
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
2010
Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe
2009
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
2014
Imminent risk of fracture after fracture
2016
Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study
2017
Ethnic Differences in Bone Health
2015
Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon
2006
Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce
2003 Standout
Osteoporosis Telephonic Intervention to Improve Medication Regimen Adherence
2012
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
Single-Site vs Multisite Bone Density Measurement for Fracture Prediction
2007
Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review
2004
The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
2007
Long-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
2006 Standout
Back Pain Exacerbations and Lost Productive Time Costs in United States Workers
2006
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
A systematic review of low back pain cost of illness studies in the United States and internationally
2008 Standout
Bone health in cancer patients: ESMO Clinical Practice Guidelines
2014
IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis
2002
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
2011
Clinical Use of Bone Densitometry
2002
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
2008
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
BMD, clinical risk factors and their combination for hip fracture prevention
2009
Sarcopenia
2019 Standout
High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study
2006
Overcoming problems with adherence to osteoporosis medication
2010
Assessment of fracture risk
2004
Use of a Case Manager to Improve Osteoporosis Treatment After Hip Fracture
2007
Partial adherence: a new perspective on health economic assessment in osteoporosis
2011
The incidence and risk of hip fracture in Poland
2008
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture
2006
Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women
2010
Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 1: Hip Geometry
2015
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
2009
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
2010
Cost–Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence
2010
FRAX® assessment of osteoporotic fracture probability in Switzerland
2009
The Assessment of Fracture Risk
2010
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
2012
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
2008
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis
2012
Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia
2018
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study
2004
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Expression of ICAM-1 by osteoblasts in healthy individuals and in patients suffering from osteoarthritis and osteoporosis
2004
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
2010
Low bone mineral density and fracture burden in postmenopausal women
2007
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial
2007
Practical Clinical Trials
2003
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women
2007
A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence
2011
Role of Dual-Energy X-Ray Absorptiometry in the Diagnosis and Treatment of Osteoporosis
2006
Chronic Kidney Disease
2016 Standout
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I
2009
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
2009 Standout
Trabecular Bone Score
2016
Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study
2008
Prevention of falls and consequent injuries in elderly people
2005 Standout
Alcohol intake as a risk factor for fracture
2004
Correlations Between Trabecular Bone Score, Measured Using Anteroposterior Dual-Energy X-Ray Absorptiometry Acquisition, and 3-Dimensional Parameters of Bone Microarchitecture: An Experimental Study on Human Cadaver Vertebrae
2011
Secondary osteoporosis and the risk of distal forearm fractures in men and women
2002
Fingerprinting food: current technologies for the detection of food adulteration and contamination
2012 Standout
MECHANISMS IN ENDOCRINOLOGY: Genetics of human bone formation
2017
Osteoporotic Vertebral Fracture Prevalence Varies Widely Between Qualitative and Quantitative Radiological Assessment Methods: The Rotterdam Study
2017
Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study
2005
Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2007
Hip Fractures Risk in Older Men and Women Associated With DXA-Derived Measures of Thigh Subcutaneous Fat Thickness, Cross-Sectional Muscle Area, and Muscle Density
2015
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Interventions for enhancing medication adherence
2008 Standout
The cost of productivity losses associated with allergic rhinitis.
2000
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
2006 Standout
Management of the patient after an osteoporotic fracture: Guidelines for orthopedic surgeons--consensus conference on Treatment of Osteoporosis for Orthopedic Surgeons, Nordic Orthopedic Federation, Tampere, Finland 2000
2001
Smoking and fracture risk: a meta-analysis
2004
In VivoAssessment of Trabecular Bone Microarchitecture by High-Resolution Peripheral Quantitative Computed Tomography
2005
Interventions for enhancing medication adherence
2014 Standout
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
2016
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses
2016 Standout
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Predictive Value of BMD for Hip and Other Fractures
2005
[A FRAX model for the assessment of fracture probability in Belgium].
2009
Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
2010
Compression fractures detection on CT
2017
Cost-Effectiveness of Different Screening Strategies for Osteoporosis in Postmenopausal Women
2011
Evidence From Data Searches and Life-Table Analyses for Gender-Related Differences in Absolute Risk of Hip Fracture After Colles' or Spine Fracture: Colles' Fracture as an Early and Sensitive Marker of Skeletal Fragility in White Men
2004
The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry
2005
Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites
2016 Standout
Medication Adherence
2009 Standout
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
2005
Algorithm-Based Qualitative and Semiquantitative Identification of Prevalent Vertebral Fracture: Agreement Between Different Readers, Imaging Modalities, and Diagnostic Approaches
2007
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
2008
Works of Thomas A. Abbott being referenced
Evaluation of Decision Rules to Identify Postmenopausal Women for Intervention Related to Osteoporosis
2003
Management of Osteoporosis in Women Aged 50 and Older with Osteoporosis-Related Fractures in a Managed Care Population
2003
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
2004
Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study
2003
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II
2009
Adherence to Bisphosphonate Therapy and Fracture Rates in Osteoporotic Women: Relationship to Vertebral and Nonvertebral Fractures From 2 US Claims Databases
2006
An Approach to Identifying Osteopenic Women at Increased Short-term Risk of Fracture
2004
Evaluation and management of osteoporosis following hospitalization for low-impact fracture
2003
Labour productivity effects of prescribed medicines for chronically ill workers
1996
The Labor Productivity Effects of Chronic Backache in the United States
1998
Evaluation of Three Population-Based Strategies for Fracture Prevention
2005
Identifying Postmenopausal Women at High Risk of Fracture in Populations: A Comparison of Three Strategies
2002
Osteoporosis and Fracture Risk in Women of Different Ethnic Groups
2005
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
2000 Standout
Prediction of Fracture Risk in Postmenopausal White Women With Peripheral Bone Densitometry: Evidence From the National Osteoporosis Risk Assessment
2002
Identification and Fracture Outcomes of Undiagnosed Low Bone Mineral Density in Postmenopausal Women: Results From the National Osteoporosis Risk Assessment
2002
Education and Phone Follow-Up in Postmenopausal Women at Risk for Osteoporosis
2005
Identification and Fracture Outcomes of Undiagnosed Low Bone Mineral Density in Postmenopausal Women
2001
An Approach to Identifying Osteopenic Women at Increased Short-term Risk of Fracture
2004